BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 19428863)

  • 1. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
    Ribeiro DP; Freitas MM; Cardoso MR; Pajuaba AC; Silva NM; Mineo TW; Silva JS; Mineo JR; Silva DA
    Vaccine; 2009 Apr; 27(19):2570-9. PubMed ID: 19428863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ArtinM, a D-mannose-binding lectin from Artocarpus integrifolia, plays a potent adjuvant and immunostimulatory role in immunization against Neospora caninum.
    Cardoso MR; Mota CM; Ribeiro DP; Santiago FM; Carvalho JV; Araujo EC; Silva NM; Mineo TW; Roque-Barreira MC; Mineo JR; Silva DA
    Vaccine; 2011 Nov; 29(49):9183-93. PubMed ID: 22001880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
    Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
    J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.
    Ramamoorthy S; Sanakkayala N; Vemulapalli R; Duncan RB; Lindsay DS; Schurig GS; Boyle SM; Kasimanickam R; Sriranganathan N
    Int J Parasitol; 2007 Nov; 37(13):1521-9. PubMed ID: 17568587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and immunostimulatory effects of a D-galactose-binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis.
    Cardoso MR; Mota CM; Ribeiro DP; Noleto PG; Andrade WB; Souza MA; Silva NM; Mineo TW; Mineo JR; Silva DA
    Vet Res; 2012 Oct; 43(1):76. PubMed ID: 23107170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
    Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
    Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice.
    Debache K; Hemphill A
    Vaccine; 2012 Jun; 30(28):4209-15. PubMed ID: 22537986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.
    Moore DP; Leunda MR; Zamorano PI; Odeón AC; Romera SA; Cano A; de Yaniz G; Venturini MC; Campero CM
    Vet Parasitol; 2005 Jun; 130(1-2):29-39. PubMed ID: 15893067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
    Tuo W; Zhao Y; Zhu D; Jenkins MC
    Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
    Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
    Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
    Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
    Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
    Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
    J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.
    Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC
    Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
    Alaeddine F; Keller N; Leepin A; Hemphill A
    J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice.
    Mansilla FC; Franco-Mahecha OL; Lavoria MÁ; Moore DP; Giraldez AN; Iglesias ME; Wilda M; Capozzo AV
    Vaccine; 2012 Feb; 30(6):1124-31. PubMed ID: 22178728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum.
    Long MT; Baszler TV; Mathison BA
    J Parasitol; 1998 Apr; 84(2):316-20. PubMed ID: 9576505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.